Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 2 | BMC Cancer

Figure 2

From: Recurrence and mortality according to Estrogen Receptor status for breast cancer patients undergoing conservative surgery. Ipsilateral breast tumour recurrence dynamics provides clues for tumour biology within the residual breast

Figure 2

Hazard rate estimates for distant metastasis in patients with ERP tumours undergoing QuaRT (1354 patients), TaRT (261 patients) and Quad (196 patients). There is virtual identity of distant recurrence dynamics for each conservative local treatment modality among ERP tumours. Vertical lines represent point-wise confidence interval for the model estimated hazards, according to standard asymptotic theory.

Back to article page